The latest on all open rulemaking projects including a signal that WSLCB intends to modify vapor product regulation in response to a widely publicized health scare.
A sparsely attended hearing provided an opportunity to learn more about the department’s Medical Marijuana Program, the patient registry, and upcoming rulemaking.
Participants shared strategies to mitigate costs and phase-in new pesticide and heavy metals testing requirements for cannabis products in Washington state.
The scope of the vaping crisis continued to expand, including a possible case in Washington state and increased likelihood of federal and state action against flavored vapor products considered appealing to children.
A new Traceability Data Sharing Agreement Work Group convenes, the lege asks for a marijuana update, and the Board confronts an emergent public health crisis attributed to vaping.
Details on the WSLCB’s social equity and Tier 1 vertical integration bills; labs; traceability; the Cannabis Potency Tax Work Group; and legislator interest in advertising loopholes.